FOLD

Amicus Therapeutics Stock Price

17.61
0.635 (3.74%)
Upgrade to Real-Time
Regular Market
17.61
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Amicus Therapeutics Inc FOLD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.635 3.74% 17.61 12:52:16
Close Price Low Price High Price Open Price Previous Close
16.89 17.64 17.09 16.975
Bid Price Ask Price Spread News
17.59 17.62 0.03 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5,995 579,605 $ 17.37 $ 10,066,676 2,095,858 6.25 - 17.67
Last Trade Time Type Quantity Stock Price Currency
12:52:13 200 $ 17.61 USD

Amicus Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.56B 258.79M 257.21M $ 182.24M $ - -1.51 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Amicus Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FOLD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week16.4017.6716.010416.942,337,3781.217.38%
1 Month13.8217.6712.7815.291,910,2803.7927.42%
3 Months14.5917.6712.77514.671,716,7333.0220.7%
6 Months11.6117.6710.4813.762,170,9026.0051.68%
1 Year8.1817.676.2511.372,531,4239.43115.28%
3 Years13.5717.676.2512.272,542,0004.0429.77%
5 Years6.7117.674.4110.792,586,81610.90162.44%

Amicus Therapeutics Description

Amicus Therapeutics Inc is a biotechnology company. It is focused on discovering, developing, and delivering novel high-quality medicines for people living with rare metabolic diseases. Amicus Therapeutics is expanding a pipeline of medicines for rare metabolic diseases, including an industry- leading rare disease gene therapy portfolio.


Your Recent History
NASDAQ
FOLD
Amicus The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.